Expert Review of Hematology
Volume 16, 2023 - Issue 10
Open access
1,622
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study
Robert F. Sidonio Jra Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA, USAView further author information
, Alexis A. Thompsonb Division of Hematology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USAView further author information
, Flora Peyvandic Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre and Fondazione Luigi Villa, Milan, Italy;d Department of Pathophysiology and Transplantation, Universitàdegli Studi diMilano, Milan, ItalyView further author information
, Oleksandra Stasyshyne Academy of Medical Sciences of Ukraine, Lviv, UkraineView further author information
, Seoh Leng Yeohf Department of Pediatrics, Hospital Pulau Pinang, George Town, MalaysiaView further author information
, Darintr Sosothikulg Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;h Integrative and Innovative Hematology/Oncology Research Unit, Faculty of Medicine, Chulalonkorn University, Bangkok, ThailandView further author information
, Ali Bulent Antmeni Department of Pediatric Hematology and Oncology, Acibadem Adana Hospital, Adana, TurkeyView further author information
, Caterina Maggiorej IQVIA, Milan, ItalyView further author information
, Werner Englk Pharmacometrics & Biostatistics, Baxalta Innovations GmbH, A Takeda Company, Vienna, AustriaView further author information
, Bruce Ewensteinl Takeda Development Center Americas, Inc., Cambridge, MA, USAView further author information
& Srilatha Tangadal Takeda Development Center Americas, Inc., Cambridge, MA, USACorrespondence[email protected]
View further author information
show allView further author information
Pages 793-801
|
Received 19 Jan 2023, Accepted 07 Aug 2023, Published online: 07 Sep 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.